| Literature DB >> 33148329 |
Jung Youb Kang1, Woonhyoung Lee2, Gwang Myeong Noh1, Bo Hyun Jeong3, Indal Park3, Sang Joon Lee4.
Abstract
BACKGROUND: Staphylococcus epidermidis is the most common pathogen in postoperative endophthalmitis and causes various infectious eye diseases. However, there is very little information on fluoroquinolone antibiotic resistance to S. epidermidis identified in conjunctival microbe and analysis of related genes. Here, the authors investigated the rate of resistance to fluoroquinolones of Staphylococcus epidermidis isolated from normal conjunctival microbes and mutations in the quinolone-resistance determining region (QRDR).Entities:
Keywords: Conjunctiva; Microbes; Mutation; QRDR; Quinolone resistance; Staphylococcus epidermidis
Year: 2020 PMID: 33148329 PMCID: PMC7640383 DOI: 10.1186/s13756-020-00841-3
Source DB: PubMed Journal: Antimicrob Resist Infect Control ISSN: 2047-2994 Impact factor: 4.887
Clinical and Laboratory Standards Institute Performance Standards for dilution antimicrobial susceptibility tests
| Antimicrobial agent | MIC (μg/mL) interpretive standard | ||
|---|---|---|---|
| Susceptible | Intermediate | Resistant | |
| Ciprofloxacin | ≤ 1 | 2 | ≥ 4 |
| Levofloxacin | ≤ 1 | 2 | ≥ 4 |
| Moxifloxacin | ≤ 0.5 | 1 | ≥ 2 |
MIC minimal inhibitory concentration
Fig. 1.Representative picture of a micro-dilutional antibiotic sensitivity test for Staphylococcus epidermidis. CFX ciprofloxacin, LFX levofloxacin, MFX moxifloxacin, S standard microorganism (susceptible strain), 80 sample number (resistant strain), PC positive control (CAMBH 80 μL + bacterial solution 10 μL), NC negative control (CAMBH 80 μL + antibiotics solution 10 μL), Small numbers above each well: concentration of antibiotics
Primers used in the study
| Target gene | Primer sequence (5′ to 3′) | Product size (bp) |
|---|---|---|
| ATGCGTGAATCATTCTTAGACTATGC | 284 | |
| GAGCCAAAGTTACCTTGACC | ||
| CAGCATTAGACGTTTCAAG | 251 | |
| CCAATACCCGTACCAAATGC | ||
| TCGCAATGTATTCAAGTGGG | 197 | |
| ATCGTTATCGATACTACCATT | ||
| AAGCTCAACAAGCACGCGAGGCTG | 324 | |
| TTAAAGTCAGTACCAACACCAGCAC |
Nucleotide positions are indicated according to GenBank sequence number NC 002976 (Staphylococcus epidermidis RP62A)
Fig. 2.Representative picture of a 1.2% agarose gel electrophoresis of polymerase chain reaction (PCR) products. Arabic numbers: sample numbers, S: 16 s rRNA, A: gyrA, B: gyrB, C: parC, E: parE
Profile of microorganisms isolated from lower conjunctival sac of eyes undergoing cataract surgery and intravitreal injection
| Gram + bacteria (n = 221) | Number of isolates (%) | Gram—bacteria (n = 82) | Number of isolates (%) |
|---|---|---|---|
| 102 (33.7%) | 33 (10.9%) | ||
| 54 (17.8%) | 11 (3.6%) | ||
| Other CNS | 30 (9.9%) | 7 (2.3%) | |
| 10 (3.3%) | 7 (2.3%) | ||
| 10 (3.3%) | 4 (1.3%) | ||
| 6 (2%) | 4 (1.3%) | ||
| 4 (1.3%) | 3 (1%) | ||
| 3 (1%) | 2 (0.7%) | ||
| 1 (0.3%) | 2 (0.7%) | ||
| 1 (0.3%) | 2 (0.7%) | ||
| 2 (0.7%) | |||
| 2 (0.7%) | |||
| 1 (0.3%) | |||
| 1 (0.3%) | |||
| 1 (0.3%) |
Susceptibility rates of Staphylococcus epidermidis (n = 82) to 3 fluoroquinolone antibiotics
| Ciprofloxacin, n (%) | Levofloxacin, n (%) | Moxifloxacin, n (%) | |
|---|---|---|---|
| Susceptible | 55 (67.1%) | 55 (67.1%) | 61 (74.4%) |
| Intermediate | 8 (9.8%) | 7 (8.5%) | 7 (8.5%) |
| Resistant | 19 (23.2%) | 20 (24.4%) | 14 (17.1%) |
Mutations in the quinolone resistance determining region (QRDR) of gyrA, gyrB, parC and parE in 21 strains of Staphylococcus epidermidis
| Mutation type | No. of isolates | Mutation | |||
|---|---|---|---|---|---|
| 1 | 7 | Ser84Phe | – | Ser80Tyr | – |
| 2 | 4 | Ser84Phe | – | Ser80Phe | – |
| 3 | 3 | Ser84Phe | – | Ser80Phe + Asp84Val | – |
| 4 | 1 | Ser84Tyr | – | Ser80Ile | – |
| 5 | 1 | Ser84Tyr | – | Ser80Ile | Lys402Arg + Asn404Ile |
| 6 | 1 | Ser84Phe | – | Ser80Phe + Asp84Val | Lys403Thr + Asn404Asp |
| 7 | 1 | Ser84Phe | – | Ser80Phe + Asp84Val | Lys402Arg + Lys403Arg |
| 8 | 1 | Ser84Tyr + Glu88Lys | – | Ser80Phe + Asp84Tyr | – |
| 9 | 1 | Ser84Phe | – | Ser80Phe | Asp434Val |
| 10 | 1 | – | – | – | – |
Mutations in the quinolone resistance determining region (QRDR) and minimal inhibitory concentrations (MIC, μg/mL)
| Mutation type | No. of isolates | Mutation | MIC (μg/mL) | |||||
|---|---|---|---|---|---|---|---|---|
| CFX(≥ 4) | LFX(≥ 4) | MFX(≥ 2) | ||||||
| 1 | 7 | Ser84Phe | – | Ser80Tyr | – | 4 | 4 | 1 |
| Ser84Phe | – | Ser80Tyr | – | 4 | 4 | 1 | ||
| Ser84Phe | - | Ser80Tyr | - | 8 | 8 | 2 | ||
| Ser84Phe | - | Ser80Tyr | - | 4 | 8 | 1 | ||
| Ser84Phe | - | Ser80Tyr | - | 2 | 4 | 1 | ||
| Ser84Phe | - | Ser80Tyr | - | 4 | 4 | 1 | ||
| Ser84Phe | - | Ser80Tyr | - | 4 | 4 | 1 | ||
| 2 | 4 | Ser84Phe | – | Ser80Phe | – | 8 | 8 | 2 |
| Ser84Phe | – | Ser80Phe | – | 16 | 8 | 1 | ||
| Ser84Phe | – | Ser80Phe | – | 8 | 8 | 2 | ||
| Ser84Phe | – | Ser80Phe | – | 8 | 8 | 2 | ||
| 3 | 3 | Ser84Phe | – | Ser80Phe + Asp84Val | – | 16 | 8 | 2 |
| Ser84Phe | – | Ser80Phe + Asp84Val | – | 32 | 8 | 2 | ||
| Ser84Phe | – | Ser80Phe + Asp84Val | – | 32 | 8 | 2 | ||
| 4 | 1 | Ser84Tyr | – | Ser80Ile | – | 32 | 8 | 2 |
| 5 | 1 | Ser84Tyr | – | Ser80Ile | Lys402Arg + Asn404Ile | 16 | 8 | 2 |
| 6 | 1 | Ser84Phe | – | Ser80Phe + Asp84Val | Lys403Thr + Asn404Asp | 16 | 8 | 2 |
| 7 | 1 | Ser84Phe | – | Ser80Phe + Asp84Val | Lys402Arg + Lys403Arg | 32 | 8 | 2 |
| 8 | 1 | Ser84Tyr + Glu88Lys | – | Ser80Phe + Asp84Tyr | – | 64 | 64 | 32 |
| 9 | 1 | Ser84Phe | – | Ser80Phe | Asp434Val | 8 | 8 | 2 |
| 10 | 1 | – | – | – | – | 2 | 2 | 8 |
CFX ciprofloxacin, LFX levofloxacin, MFX moxifloxacin